MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia

Fiona C. Brown, Eric Still, Richard P. Koche, Christina Y. Yim, Sumiko Takao, Paolo Cifani, Casie Reed, Shehana Gunasekera, Scott B. Ficarro, Peter Romanienko, Willie Mark, Craig McCarthy, Elisa de Stanchina, Mithat Gonen, Venkatraman Seshan, Patrick Bhola, Conor O’Donnell, Barbara Spitzer, Crystal Stutzke, Vincent Philippe LavalléeJosée Hébert, Andrei V. Krivtsov, Ari Melnick, Elisabeth M. Paietta, Martin S. Tallman, Anthony Letai, Guy Sauvageau, Gayle Pouliot, Ross Levine, Jarrod A. Marto, Scott A. Armstrong, Alex Kentsis

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences